-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q2 2020 to Q4 2023.
- InMed Pharmaceuticals Inc. Return On Equity for the quarter ending December 31, 2023 was -54.3 %, a 63.8% increase year-over-year.
- InMed Pharmaceuticals Inc. annual Return On Equity for 2023 was -63.8 %, a 57.7% increase from 2022.
- InMed Pharmaceuticals Inc. annual Return On Equity for 2022 was -151 %, a 10.4% decline from 2021.
- InMed Pharmaceuticals Inc. annual Return On Equity for 2021 was -137 %, a 30% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)